Abbott India recalls batch of Thyronorm due to labelling error

“This is due to a labelling error in a small percentage of bottles from this batch which has been mislabeled with the dose strength as 25 mcg, whereas the bottles contain 88 mcg tablets,” the drug maker stated. The batch has been invoiced only in Madhya Pradesh and Telangana, it added.